Stephen Wilton
Fortune : 75 911 $ au 30/06/2026
Fortune : 75 911 $ au 30/06/2026
Stephen Wilton is currently an Independent Director at BioSyent, Inc. since 2014.
Formerly, Mr. Wilton was Executive Director-Business Development at AstraZeneca Pharmaceuticals LP from 1993 to 2010 and Vice President-Pharmacy Affairs at The Canadian Association of Chain Drug Stores from 2011 to 2012.
Education includes an undergraduate degree from the University of Toronto and an MBA from The Schulich School of Business.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOSYENT INC. 0,07% | 24/03/2026 | 7 435 ( 0,07% ) | 75 911 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIOSYENT INC. | Directeur/Membre du Conseil | 16/01/2014 |
| Sociétés | Poste | Fin |
|---|---|---|
The Canadian Association of Chain Drug Stores | Corporate Officer/Principal | 01/01/2012 |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
BioSyent, Inc.
BioSyent, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
The Canadian Association of Chain Drug Stores | |
The Schulich School of Business
The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national